Tag Archives: analyst

Biohaven’s ambitious Nurtec ODT marketing strategy pays dividends with doctors in migraine market: analyst

Biohaven went all-in on marketing its added preventative indication for oral migraine med Nurtec. And now it’s reaping the rewards with doctors. Three months post-approval, 96% of neurologists were aware of the brand, while 65% are “highly familiar” with it, according to Spherix Global Insights’ postlaunch report. Nurtec easily bested bigger migraine players postlaunch familiarity including Amgen’s… Read More »

Here are all the areas in health care Amazon could look to expand to, according to one analyst

Retail giant Amazon‘s expansion into health care has already begun, but there’s a lot more room for it to grow, Loop Capital Markets’ Anthony Chukumba told CNBC on Tuesday. Chukumba said on “The Exchange” that he sees $ 72 billion of potential for Amazon through continued health-care expansion, which accelerated in 2018 when it purchased… Read More »

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »